Journal article
Purine nucleoside analogues: fludarabine, pentostatin, and cladribine: Part 2: Pentostatin
Journal of oncology pharmacy practice, Vol.2(4), pp.211-224
12/1996
DOI: 10.1177/107815529600200403
Abstract
Purpose. The primary objective of this article is to continue the discussion of the pharmacology, phar macokinetics, clinical use, and adverse effects of the currently approved adenosine analogues, focusing on pentostatin. This is part two of a three part series.
Data Sources. We reviewed the literature through a MEDLINE search from 1986 to 1996. Rele vant articles cited in the literature obtained by MED LINE searching also were considered. We searched the following terms: fludarabine, cladribine, pentosta tin, apoptosis, and adenosine analogues. The search was restricted to the English language.
Data Extraction. We have reviewed the current literature in regard to the chemistry, mechanisms of action and pharmacology, pharmacokinetics, clinical use, adverse effects, drug interactions, indications, formulation, dosage, administration, and pharmaceu tical issues of the currently approved adenosoine analogues, focusing on pentostatin.
Data Synthesis. The adenosine analogues are structurally similar agents used in the management of hematological malignancies. Pentostatin and cladrib ine are both active agents in the treatment of hairy cell leukemia. There are no comparative clinical trials between the agents, and we have provided compari sons based on pharmacology, clinical experience, adverse effects, and cost.
Details
- Title: Subtitle
- Purine nucleoside analogues: fludarabine, pentostatin, and cladribine: Part 2: Pentostatin
- Creators
- Jill M. Kolesar - University of Wisconsin–MadisonAshley K. Morris - The University of Texas Health Science Center at San AntonioJohn G. Kuhn - The University of Texas Health Science Center at San Antonio
- Resource Type
- Journal article
- Publication Details
- Journal of oncology pharmacy practice, Vol.2(4), pp.211-224
- DOI
- 10.1177/107815529600200403
- ISSN
- 1078-1552
- eISSN
- 1477-092X
- Language
- English
- Date published
- 12/1996
- Academic Unit
- Pharmacy; Pharmaceutical Sciences and Experimental Therapeutics
- Record Identifier
- 9984695788202771
Metrics
1 Record Views